CN101585839A - 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone and synthetic method thereof - Google Patents

6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone and synthetic method thereof Download PDF

Info

Publication number
CN101585839A
CN101585839A CNA200910048342XA CN200910048342A CN101585839A CN 101585839 A CN101585839 A CN 101585839A CN A200910048342X A CNA200910048342X A CN A200910048342XA CN 200910048342 A CN200910048342 A CN 200910048342A CN 101585839 A CN101585839 A CN 101585839A
Authority
CN
China
Prior art keywords
ketone
methoxyl group
trifluoromethyl
benzo
imidazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200910048342XA
Other languages
Chinese (zh)
Inventor
郝健
侯明华
庄红伟
高岩
万文
蒋海珍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Shanghai for Science and Technology
Original Assignee
University of Shanghai for Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Shanghai for Science and Technology filed Critical University of Shanghai for Science and Technology
Priority to CNA200910048342XA priority Critical patent/CN101585839A/en
Publication of CN101585839A publication Critical patent/CN101585839A/en
Pending legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

The present invention relates to a kind of 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone and synthetic method thereof, the structural formula of this compound is: this method has following steps: trifluoro γ-ketone acid methyl esters and catalytic dosage of paratoluenesulfonic acid are dissolved in the toluene, the anhydrous magnesium sulfate that adds catalyst levels again, stirring down, back flow reaction adds after 20~60 minutes the methoxyl group O-Phenylene Diamine, continue reaction and add catalytic dosage of paratoluenesulfonic acid again after 10~15 hours, back flow reaction 10~15 hours, reaction finishes, through separation and purification, get white solid and be 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone.6-methoxyl group-3a-of the present invention (trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone should have stronger activity, more helps absorbing.Raw material of the present invention is easy to get, and operates very simply, and one kettle way is synthetic, and productive rate is fit to scale operation up to 78%.

Description

6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone and synthetic method thereof
Technical field:
The present invention relates to a kind of is 3 '-Trifluoromethyl-1-methoxyl group benzo imidazoles 2-pyrrolidinone derivative and synthetic method thereof, particularly a kind of 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone and synthetic method thereof.
Background technology:
Nitrogen-containing heterocycle compound is a part important in the organic compound, and it has almost accounted for the overwhelming majority of heterogeneous ring compound.Nitrogen-containing heterocycle compound has a wide range of applications in field of fine chemical such as agricultural chemicals, medicine, dyestuff, is the focus that people study all the time.
Benzoglyoxaline lopps compound has certain property of medicine as a kind of important nitrogen-containing heterocycle compound, is present in the minority medicine.They are widely used in the control of agricultural disease worm, control and other industrial circles of human body diseases.And the benzimidazoles medicine is to the mammal low toxicity, is a kind of antiparasitic of efficient, wide spectrum.Pyrrolidone compound also is the very high compound of a class using value, is important medicine intermediate, is the raw material of producing piracetam, Myelosan etc., also is the raw material of producing Polyvinylpyrolidone (PVP) (burn medicine).The benzoglyoxaline pyrrolidone compound is the bis-heterocyclic compounds that contains two nitrogen heteroatoms, and structure is special, and their polymkeric substance is widely used as heat-resisting gas separation membrane material usually.
As far back as eighties of last century document (Chimirri, A. were just arranged in the eighties; Sarro, A.D.; Sarro, G.D.; Grasso, S.; Trimarchi, G.R.J.Med.Chem.1989,32, reported that 93-95.) the benzoglyoxaline 2-pyrrolidinone derivative has anti-epileptic, antitetanic physiologically active, can be applicable in the medicine.There is phenyl ring the benzoglyoxaline pyrrolones derivative 3a position of being reported in this piece article, and on the phenyl ring electron-withdrawing group is arranged.
The synthetic method of this compound does not have report at present as yet.
Summary of the invention:
One of purpose of the present invention is to provide a kind of new compound 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone.
Two of purpose of the present invention is to provide the synthetic method of this compound.
For achieving the above object, the reaction mechanism that the inventive method adopts is:
Figure A20091004834200031
According to above-mentioned reaction mechanism, the present invention adopts following technical scheme:
A kind of 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone is characterized in that the structure of this compound is:
Figure A20091004834200041
6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, the physical parameter of 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-this compound of 1-ketone:
Molecular formula: C 12H 11F 3N 2O 2
Structural formula:
Figure A20091004834200042
Chinese named: 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, the English name of 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone: 6-methoxy-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydro-1H-benzo[d] pyrrolo[1,2-a] imidazol-1-one
Molecular weight: 272.08
Outward appearance: white solid
Fusing point: 113.5~115.4
Infrared spectra (adopting the Perkin-Elmer983G infrared spectrometer, liquid-film method):
v?max(cm -1):3342,3004,2931,1921,1868,1716,1610,1499,1454,1390,1194,1171,1069,1060,979,884,847,820
Proton nmr spectra (500MHz, CDCl 3): 7.346,7.329 (d, J=8.5Hz, 1H, ArH); 6.355,6.338,6.324 (t, J=7.75Hz, 2H, ArH); 4.847 (s, 1H, NH); 3.736 (s, 3H, Ar-OCH 3); 2.929~2.855 (m, 1H, CH 2); 2.809,2.783,2.765 (t, J=11Hz, 1H, CH 2); 2.572,2.5455,2.519 (t, J=13.25Hz, 1H, CH 2); 2.439,2.417,2.394,2.372 (q, J=11.2Hz, 1H, CH 2)
Nucleus magnetic resonance fluorine spectrum (470MHz, CDCl 3, interior mark: C 6F 6): δ=-86.27 (s)
Carbon-13 nmr spectra (125MHz, CDCl 3): 177.74; 158.40; 142.70; 127.91; 125.61,123.32,121.02 (J=287.5Hz); 123.60; 115.40; 103.94; 98.12; 85.92,85.67,85.41,85.16 (J=31.25Hz); 55.65; 32.68; 31.14
A kind of synthetic above-mentioned 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] method of imidazoles-1-ketone, the concrete steps that it is characterized in that this method are: trifluoro γ-ketone acid methyl esters and catalytic dosage of paratoluenesulfonic acid are dissolved in the toluene, the anhydrous magnesium sulfate that adds catalyst levels again, stirring down, back flow reaction adds after 20~60 minutes the methoxyl group O-Phenylene Diamine, continue reaction and add catalytic dosage of paratoluenesulfonic acid again after 10~15 hours, back flow reaction 10~15 hours, reaction finishes, through separation and purification, get white solid and be 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone.
In the pharmaceutical chemistry field, fluorine atom or one contain fluoroalkyl and are incorporated into and are considered to one of most effectual way that host compound is modified in the host molecule.Because the fluorine atom radius is little, has bigger electronegativity again, its formed C-F key bond energy is than big many of c h bond bond energy, the stability and the physiologically active of organofluorine compound have been increased significantly, fluorinated organic compound also has higher fat-soluble and hydrophobicity in addition, promote it to absorb in vivo and transmission speed, physiological action is changed.Have characteristics such as consumption is few, toxicity is low, drug effect is high, metabolic capacity is strong so a lot of fluorine-containing medicines and agricultural chemicals are relative on performance, this makes its proportion in the new pharmaceutical pesticide species more and more higher.The fluoro-containing group trifluoromethyl that the handle of the invention has an electrophilic function is incorporated into the 3a position of benzoglyoxaline pyrrolones derivative, replace the phenyl ring that has the electrophilic function originally, make 6-methoxyl group-3a-of the present invention (trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone should have stronger activity, more helps absorbing.The inventive method raw material is easy to get, and operates very simply, and one kettle way is synthetic, and productive rate 78% is fit to scale operation.
Embodiment:
Embodiment 1: 1. add trifluoro γ-ketone acid methyl esters 0.44 gram in 50 milliliters the round-bottomed flask that reflux condensing tube is housed, p-methyl benzenesulfonic acid 0.019 gram, 25 milliliters of toluene, anhydrous magnesium sulfate 0.2 gram.Said mixture stirring and refluxing in oil bath adds after half an hour methoxyl group O-Phenylene Diamine 0.276 gram; 2. reactant reaction solution yellowing gradually under refluxing.React and add 0.019 gram p-methyl benzenesulfonic acid after 12 hours again.Continue reaction 12 hours, then stopped reaction.Suction filtration was removed anhydrous magnesium sulfate, concentrated filtrate after reaction finished.3. the concentrated solution that obtains is separated with silica gel column chromatography, developping agent is that volume ratio is 8: 1 the sherwood oil and the mixed solvent of ethyl acetate, gets white solid 0.42 gram, and productive rate is 78%.
Embodiment 2: 1. add trifluoro γ-ketone acid methyl esters 11 grams in 250 milliliters the round-bottomed flask that reflux condensing tube is housed, p-methyl benzenesulfonic acid 0.475 gram, 150 milliliters of toluene, anhydrous magnesium sulfate 5 grams.Said mixture stirring and refluxing in oil bath adds after half an hour methoxyl group O-Phenylene Diamine 6.9 grams; 2. reactant reaction solution yellowing gradually under refluxing.React and add 0.475 gram p-methyl benzenesulfonic acid after 12 hours again.Continue reaction 16 hours, then stopped reaction.Suction filtration was removed anhydrous magnesium sulfate, concentrated filtrate after reaction finished.3. the concentrated solution that obtains is separated with silica gel column chromatography, developping agent is that volume ratio is 8: 1 the sherwood oil and the mixed solvent of ethyl acetate, gets white solid 10.2 grams, and productive rate is 75%.
Embodiment 3: 1. add trifluoro γ-ketone acid methyl esters 110 grams in 2 liters the round-bottomed flask that reflux condensing tube is housed, p-methyl benzenesulfonic acid 4.75 grams, 1000 milliliters of toluene, anhydrous magnesium sulfate 25 grams.Said mixture stirring and refluxing in oil bath adds after half an hour 2. methoxyl group O-Phenylene Diamine 69 is restrained reactant reaction solution yellowing gradually under refluxing.React and add 4.75 gram p-methyl benzenesulfonic acids after 12 hours again.Continue reaction 23 hours, then stopped reaction.Suction filtration was removed anhydrous magnesium sulfate, concentrated filtrate after reaction finished.3. the concentrated solution that obtains is separated with silica gel column chromatography, developping agent is that volume ratio is 6: 1 the sherwood oil and the mixed solvent of ethyl acetate, gets white solid 99.3 grams, and productive rate is 73%.

Claims (2)

1. a 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone is characterized in that the structure of this compound is:
Figure A2009100483420002C1
2. one kind is synthesized 6-methoxyl group-3a-according to claim 1 (trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] method of imidazoles-1-ketone, it is characterized in that this method has following steps: trifluoro γ-ketone acid methyl esters and catalytic dosage of paratoluenesulfonic acid are dissolved in the toluene, the anhydrous magnesium sulfate that adds catalyst levels again, stirring down, back flow reaction adds after 20~60 minutes the methoxyl group O-Phenylene Diamine, continue reaction and add catalytic dosage of paratoluenesulfonic acid again after 10~15 hours, back flow reaction 10~15 hours, reaction finishes, through separation and purification, get white solid and be 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone.
CNA200910048342XA 2009-03-26 2009-03-26 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone and synthetic method thereof Pending CN101585839A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA200910048342XA CN101585839A (en) 2009-03-26 2009-03-26 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone and synthetic method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA200910048342XA CN101585839A (en) 2009-03-26 2009-03-26 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone and synthetic method thereof

Publications (1)

Publication Number Publication Date
CN101585839A true CN101585839A (en) 2009-11-25

Family

ID=41370291

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200910048342XA Pending CN101585839A (en) 2009-03-26 2009-03-26 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone and synthetic method thereof

Country Status (1)

Country Link
CN (1) CN101585839A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10053817B2 (en) 2010-04-27 2018-08-21 Fiberlean Technologies Limited Process for the manufacture of structured materials using nano-fibrillar cellulose gels

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10053817B2 (en) 2010-04-27 2018-08-21 Fiberlean Technologies Limited Process for the manufacture of structured materials using nano-fibrillar cellulose gels

Similar Documents

Publication Publication Date Title
CA2584757A1 (en) Halogen substituted benzodiazepine derivatives
CN102070576A (en) 1-indanone-3-acetic acid compound as well as preparation method and application of 1-indanone-3-acetic acid compound
CN102627653A (en) Preparation method of irinotecan hydrochloride
CN101591338B (en) Method for synthesizing indiplon
CN101585839A (en) 6-methoxyl group-3a-(trifluoromethyl)-2,3,3a, 4-tetrahydrochysene-1H-benzo [d] pyrroles [1,2-a] imidazoles-1-ketone and synthetic method thereof
CN101020662A (en) Compound 3,4-diaryl pyrazole and its prepn and medicinal use
CN101514205A (en) 7a-(difluoromethyl)tetrahydro-1H-pyrrolo[1,2-alpha]imidazole-5(6H)-ketone and synthetic method thereof
CN102911123B (en) Preparation method of 2-chloro trifluoromethyl pyrimidine compound
CN101514206A (en) 7a-(trifluoromethyl)-8,9-dihydro-7H-pyrrolo[1,2-a]perimidine-10(7alphaH)-ketone and synthetic method thereof
CN1164585C (en) Xanthiphenyl ketamine or its salt and its preparing process
CN101544648A (en) 3a-(trifluoromethyl)-2,3,3a,4-tetrahydro-1H-benzene[d]pyrrole[1,2-a]imidazole-1-ketone and synthesis method thereof
CN101514203A (en) 7-nitryl-3a-(trifluoromethyl)-2,3,3a,4-tetrahydrogen-1H-benzo(d) pyrrole (1,2-a) imidazole-1-ketone and synthesis method thereof
CN101544645A (en) 6-flourine-3a-(trifluoromethyl)-2,3,3a,4-tetrahydro-1H-benzo[d]pyrrole[1,2-a]imidazole-1-ketone and method for synthesizing same
CN105017238A (en) Method for chiral spirophosphonate catalyzed synthesis of optically active 2H-1,4-benzoxazine-2-one derivative
CN101544608B (en) 5-(2-(trifluoromethyl)-2,3-dihydro-1H-benzoglioxaline) methyl valerate and synthesis method thereof
CN101531662A (en) (3aS, 4aR, 8aR)-3a-(trifluoromethyl)+hydrogen-1H-benzo (d) pyrrole (1, 2-a)-imidazole-1-ketone and synthetic method thereof
CN101514204A (en) 7a-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-a]imidazole-5(6H)-ketone and synthetic method thereof
CN101544646A (en) 3a-(difluoromethyl)-2,3,3a-tetrahydro-1H-benzene[d]pyrrole[1,2-a]thiazole-1-ketone and synthesis method thereof
CN101544663A (en) 3a-(trifluoromethyl)-3,3a-dihydrobenzene[d]pyrrole[2,1-b]thiazole-1(2H)-ketone and synthesis method thereof
CN101514202A (en) 9a-(trifluoromethyl) hexahydrogen-1H-pyrrolo(1,2-a) diazepine-7(8H)-ketone and synthesis method thereof
CN101544647A (en) (4aR,8aR)-3a-(difluoromethyl)decahydro-1H-benzene[d]pyrrole[1,2-a]-thiazole-1-ketone and synthesis method thereof
CN101531669A (en) 7-chlorine-3a-(trifluoromethyl)-3, 3a-dihydrobenzo (d) pyrrole (2, 1-b)-oxazole-1(2H)-ketone and synthetic method thereof
CN1166660C (en) Process for preparing N-methyl piperethanamine salt
CN101544656A (en) (3R)-3-benzyl-7a-(trifluoromethyl)tetrahydropyrrolo[2,1-b]oxazole-5(6H)-ketone and synthesis method thereof
CN101531670A (en) 7-methyl-3a-(trifluoromethyl)-3, 3a-dihydrobenzo (d) pyrrole (2, 1-b)-oxazole-1(2H)-ketone and synthetic method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20091125